BIOMAT Database Logo BIOMAT Database Logo

[Experiences with a combination of bemetizide and triamterene in the ambulatory treatment of hypertension. Report of a multicentric study]. 1978

A Schrey, and G Schmidt, and W J Ziegler

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004232 Diuretics Agents that promote the excretion of urine through their effects on kidney function. Diuretic,Diuretic Effect,Diuretic Effects,Effect, Diuretic,Effects, Diuretic
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Schrey, and G Schmidt, and W J Ziegler
[Treatment of hypertension with bupranolol, bemetizide and triamterene].
October 1982, Deutsche medizinische Wochenschrift (1946),
A Schrey, and G Schmidt, and W J Ziegler
[Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].
January 1982, Wiener klinische Wochenschrift,
A Schrey, and G Schmidt, and W J Ziegler
Bioavailability of bemetizide and triamterene from a combination formulation.
January 1982, Biopharmaceutics & drug disposition,
A Schrey, and G Schmidt, and W J Ziegler
Placebo-controlled trial of a combination of bemetizide and triamterene ('Hypertane') in mild or moderate hypertension.
January 1983, Current medical research and opinion,
A Schrey, and G Schmidt, and W J Ziegler
[Effect of triamterene and bemetizide on transcapillary water metabolism].
May 1975, Die Medizinische Welt,
A Schrey, and G Schmidt, and W J Ziegler
Hydrochlorothiazide/triamterene combination: once daily in the treatment of hypertension.
May 1984, The British journal of clinical practice,
A Schrey, and G Schmidt, and W J Ziegler
[Diuretic and saluretic effects of bemetizide and triamterene compared to those of their combination (author's transl)].
January 1977, Arzneimittel-Forschung,
A Schrey, and G Schmidt, and W J Ziegler
[Beta blockader treatment in ambulatory hypertension care. A multicentric long-term study].
May 1980, ZFA. Zeitschrift fur Allgemeinmedizin,
A Schrey, and G Schmidt, and W J Ziegler
[Hypotensive effects of fursemide, triamterene and reserpine combination in patients with essential hypertension on ambulatory care].
November 1971, Revista paulista de medicina,
A Schrey, and G Schmidt, and W J Ziegler
Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
January 1983, Current medical research and opinion,
Copied contents to your clipboard!